BiotechTube
Home/Japan Bio Product/Satoshi Furukawa
SF

Satoshi Furukawa

Corporate Auditor

Japan Bio Product

Therapeutic Areas

Regenerative MedicineHepatologyAesthetic Medicine

Japan Bio Product Pipeline

DrugIndicationPhase
LAENNEC® (Human Placental Extract Injection)Liver Cirrhosis / Regenerative TherapyApproved (Japan/Asia)

Leadership Team at Japan Bio Product

HS
Hong Seok Lim
President and Representative Director
TK
Taiichi Kaku
Director
YK
Yumiko Kaku
Director
View full Japan Bio Product profile